Insperity (NSP) Highlights HRScale Demand, Is The Stock A Bargain?

Insperity (NSP) just put its HRScale solution back in the spotlight by tying fresh client feedback and new 3Sixty Insights research to demand for service-enabled HCM support among growing and midsized businesses.

Against that product backdrop, Insperity’s 1-day share price return of 2.32% and 7-day share price return of 1.39% hint at fresh interest, even though the 30-day share price return declined 8.47% while the year-to-date share price return is 23.15%, and over the longer term the 5-year total shareholder return has fallen 51.09%. This indicates that recent momentum is building off a weak multi-year base.

Scan beyond Insperity and this HRScale story by reviewing a curated set of peers in service-focused business solutions through the 19 high quality undiscovered gems.

Insperity has enjoyed a solid rebound this year after a rough multi year stretch and fresh HRScale interest. Has the bigger upside already played out, or does the current valuation still leave meaningful room ahead?

Most Popular Narrative: 8% Undervalued

On the most followed view of Insperity, a fair value of $51.75 sits modestly above the latest $47.56 close. This puts the debate on whether the HRScale rollout and margin repair work can genuinely shift earnings power over the next few years.

The rollout of Insperity HRScale with Workday to mid-sized clients between 150 and 5,000 employees, now with about 8,000 worksite employees sold and a shift of spending from development to revenue-producing operations, points to a new revenue stream that management expects to carry profitability at or above HR360 levels and support earnings growth.

See why 6 investors see Insperity as 8% undervalued.

Result: Fair Value of $51.75 (UNDERVALUED)

Still, the Insperity story can break if healthcare costs outpace repricing efforts, or if HRScale and Workday traction stalls and leaves expenses running ahead of revenue.

Find out about the key risks to this Insperity narrative.

Next Steps

Mixed messages run through this Insperity story, with rebounding interest sitting alongside a tough multi year record and live execution questions. Act quickly and test the bullish and cautious data points yourself, starting with the 3 key rewards and 1 important warning sign.

Looking for more ideas beyond Insperity?

If Insperity has sharpened your focus, keep that momentum going by scanning broader opportunities that match your style instead of waiting for the next headline to arrive.

• Target potential mispricings by filtering for resilient businesses that look overlooked using the 27 high quality undervalued stocks.
• Strengthen your income stream by focusing on companies with hefty payouts through the 7 dividend fortresses.
• Dial down risk and still stay invested by zeroing in on sturdier balance sheets via the list of solid balance sheet and fundamentals (25 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com